Notably, the deletion of IL-1R2 was associated with increased CD8+ T cell exhaustion and enhanced antigen presentation by dendritic cells, suggesting that IL-1R2 modulates both the immunogenicity of tumor cells and the functionality of key immune populations within the TME. This evidence concerns the gene CD8A and neoplasm.